Debt-to-equity in % of ANAVEX LIFE SCIENCES CORP. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Anavex Life Sciences Corp. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • Anavex Life Sciences Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 12.8 %, a 36.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 12.8 +3.41 +36.1% 30 Sep 2025
Q2 2025 13.6 +5.03 +58.8% 30 Jun 2025
Q1 2025 12.5 +4.33 +53% 31 Mar 2025
Q4 2024 10 +1.23 +14% 31 Dec 2024
Q3 2024 9.43 +0.49 +5.48% 30 Sep 2024
Q2 2024 8.55 +0.02 +0.24% 30 Jun 2024
Q1 2024 8.16 31 Mar 2024
Q4 2023 8.8 31 Dec 2023
Q3 2023 8.94 30 Sep 2023
Q2 2023 8.52 30 Jun 2023
Q3 2016 29.4 -20.8 -41.4% 30 Sep 2016
Q2 2016 23.5 -117 -83.3% 30 Jun 2016
Q1 2016 22.3 -113 -83.6% 31 Mar 2016
Q4 2015 23.2 -83.1 -78.2% 31 Dec 2015
Q3 2015 50.1 -38.9 -43.7% 30 Sep 2015
Q2 2015 141 +68.3 +94.3% 30 Jun 2015
Q1 2015 135 -1.27K -90.3% 31 Mar 2015
Q4 2014 106 +211 31 Dec 2014
Q3 2014 89.1 +193 30 Sep 2014
Q2 2014 72.5 +173 30 Jun 2014
Q1 2014 1.4K +1.5K 31 Mar 2014
Q4 2013 -105 -2.23 -2.17% 31 Dec 2013
Q3 2013 -104 -0.77 -0.75% 30 Sep 2013
Q2 2013 -101 +4.99 +4.72% 30 Jun 2013
Q1 2013 -101 +22.4 +18.1% 31 Mar 2013
Q4 2012 -103 31 Dec 2012
Q3 2012 -103 30 Sep 2012
Q2 2012 -106 30 Jun 2012
Q1 2012 -123 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.